Form 4 Tracker
Arturo Molina MD

Chief Medical Officer · 3 filings · Latest: Mar 26, 2026

Protagonist Therapeutics, Inc
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
PTGX
Arturo Molina MDChief Medical OfficerMar 26, 2026
Sale
$104.7915,000$1.6M84,115
PTGX
Arturo Molina MDChief Medical OfficerMar 26, 2026
Option Exercise
$8.0415,000$120.6K99,115
PTGX
ARTURO MOLINAMar 26, 2026
Proposed Sale
$104.7915,000$1.6M
PTGX
Arturo Molina MDChief Medical OfficerJan 27, 2026
Sale
$82.005,000$410.0K84,115
PTGX
Arturo Molina MDChief Medical OfficerJan 27, 2026
Option Exercise
$8.045,000$40.2K89,115
PTGX
Arturo Molina MDChief Medical OfficerJan 26, 2026
Sale
$82.285,000$411.4K84,115
PTGX
Arturo Molina MDChief Medical OfficerJan 26, 2026
Option Exercise
$8.045,000$40.2K89,115
PTGX
Arturo Molina MDChief Medical OfficerJan 23, 2026
Sale
$82.4213,151$1.1M84,115
PTGX
ARTURO MOLINAJan 27, 2026
Proposed Sale
$82.005,000$410.0K
PTGX
ARTURO MOLINAJan 26, 2026
Proposed Sale
$82.285,000$411.4K
PTGX
ARTURO MOLINAJan 23, 2026
Proposed Sale
$83.4213,151$1.1M
PTGX
Arturo Molina MDChief Medical OfficerJan 20, 2026
Sale
$82.489,514$784.7K97,266
PTGX
ARTURO MOLINA MDJan 20, 2026
Proposed Sale
$82.489,514$784.7K
PTGX
ARTURO MOLINAJun 10, 2025
Proposed Sale
$57.0310,000$570.3K
PTGX
ARTURO MOLINAJun 9, 2025
Proposed Sale
$55.5110,000$555.1K
PTGX
MOLINA ARTURO MDMar 13, 2025
Proposed Sale
$55.0030,514$1.7M
PTGX
MOLINA ARTURO MDNov 27, 2024
Proposed Sale
$44.0016,000$704.0K
PTGX
MOLINA ARTURO MDNov 26, 2024
Proposed Sale
$45.0016,000$720.0K